These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36463152)

  • 1. Changes in Fasting plasma glucose status and risk of mortality events in individuals without diabetes over two decades of Follow-up: a pooled cohort analysis.
    Kohansal K; Masrouri S; Khalili D; Ramezankhani A; Azizi F; Blaha MJ; Hadaegh F
    Cardiovasc Diabetol; 2022 Dec; 21(1):267. PubMed ID: 36463152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of BMI with all-cause mortality in normoglycemia, impaired fasting glucose and type 2 diabetes mellitus among an elderly Chinese population: a cohort study.
    Song R; Chen X; He K; Hu X; Bai K; Shi W; Shi S
    BMC Geriatr; 2022 Aug; 22(1):690. PubMed ID: 35987565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis).
    Yeboah J; Bertoni AG; Herrington DM; Post WS; Burke GL
    J Am Coll Cardiol; 2011 Jul; 58(2):140-6. PubMed ID: 21718910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
    Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
    Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose Study.
    Hadaegh F; Abdi A; Kohansal K; Hadaegh P; Azizi F; Tohidi M
    Front Endocrinol (Lausanne); 2023; 14():1164771. PubMed ID: 37305040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study.
    Asgari S; Masrouri S; Khalili D; Azizi F; Hadaegh F
    Front Cardiovasc Med; 2022; 9():1018403. PubMed ID: 36386371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes progression from "high-normal" glucose in school teachers.
    Moriuchi T; Oka R; Yagi K; Miyamoto S; Nomura H; Yamagishi M; Mabuchi H; Kobayashi J; Koizumi J
    Intern Med; 2010; 49(13):1271-6. PubMed ID: 20606358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of menopausal status on onset of impaired fasting glucose and type 2 diabetes mellitus].
    Wen JB; Yang S; Zhao XH; Chen YC; Zhao HL; Chen XT; Shen C
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):728-733. PubMed ID: 28763923
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid risk factors among elderly with normal fasting glucose, impaired fasting glucose and type 2 diabetes mellitus. The Italian longitudinal study on aging.
    Noale M; Maggi S; Zanoni S; Limongi F; Zambon S; Crepaldi G
    Nutr Metab Cardiovasc Dis; 2013 Mar; 23(3):220-6. PubMed ID: 21937208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year change in glycemic state and the future risk of incident hypertension among Iranian adults: Tehran Lipid and Glucose Study.
    Moazzeni SS; Dehghani S; Hasheminia M; Hizomi Arani R; Azizi F; Hadaegh F
    J Hum Hypertens; 2023 Oct; 37(10):944-949. PubMed ID: 36473941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers.
    Inoue K; Matsumoto M; Kobayashi Y
    Diabetes Res Clin Pract; 2007 Sep; 77(3):451-8. PubMed ID: 17346846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in fasting blood glucose status and incidence of cardiovascular disease: The China-PAR project.
    Tong Y; Liu F; Huang K; Li J; Yang X; Chen J; Liu X; Cao J; Chen S; Yu L; Zhao Y; Wu X; Zhao L; Li Y; Hu D; Huang J; Lu X; Shen C; Gu D
    J Diabetes; 2023 Feb; 15(2):110-120. PubMed ID: 36639363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and risk of all-cause mortality with normoglycemia, impaired fasting glucose and prevalent diabetes: results from the Rural Chinese Cohort Study.
    Zhao Y; Liu Y; Sun H; Sun X; Yin Z; Li H; Ren Y; Wang B; Zhang D; Liu X; Liu D; Zhang R; Liu F; Chen X; Liu L; Cheng C; Zhou Q; Hu D; Zhang M
    J Epidemiol Community Health; 2018 Nov; 72(11):1052-1058. PubMed ID: 30042126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal Fasting Glucose Increases Risk of Unrecognized Myocardial Infarctions in an Elderly Cohort.
    Stacey RB; Zgibor J; Leaverton PE; Schocken DD; Peregoy JA; Lyles MF; Bertoni AG; Burke GL
    J Am Geriatr Soc; 2019 Jan; 67(1):43-49. PubMed ID: 30298627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Burden and Disease and Mortality Risk Associated with Impaired Fasting Glucose in Elderly Adults.
    Samaras K; Crawford J; Lutgers HL; Campbell LV; Baune BT; Lux O; Brodaty H; Trollor JN; Sachdev P
    J Am Geriatr Soc; 2015 Jul; 63(7):1435-42. PubMed ID: 26147402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting plasma glucose and HbA1c levels predict the risk of type 2 diabetes and diabetic retinopathy in a Thai high-risk population with prediabetes.
    Washirasaksiri C; Srivanichakorn W; Borrisut N; Sitasuwan T; Tinmanee R; Kositamongkol C; Ariyakunaphan P; Auesomwang C; Sayabovorn N; Chaisathaphol T; Phisalprapa P
    Front Pharmacol; 2022; 13():950225. PubMed ID: 36267289
    [No Abstract]   [Full Text] [Related]  

  • 19. Waist circumference and end-stage renal disease based on glycaemic status: National Health Insurance Service data 2009-2018.
    Cho YK; Huh JH; Moon S; Kim YJ; Kim YH; Han KD; Kang JG; Lee SJ; Ihm SH
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):585-595. PubMed ID: 36564188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose.
    Dagogo-Jack S; Askari H; Tykodi G
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2031-6. PubMed ID: 19276238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.